article Open AccessTop 1% cited
Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
Mayo Clinic Proceedings · 2009 · Vol. 84(12) · pp. 1095–1110
Shaji Kumar✉(Mayo Clinic)Joseph Mıkhael(Mayo Clinic in Arizona)Francis K. Buadi(Mayo Clinic in Arizona)David Dingli(Mayo Clinic in Arizona)Angela Dispenzieri(Mayo Clinic in Arizona)Rafaël Fonseca(Mayo Clinic in Arizona)Morie A. Gertz(Mayo Clinic in Arizona)Philip R. Greipp(Mayo Clinic in Arizona)Suzanne R. Hayman(Mayo Clinic in Arizona)Robert A. Kyle(Mayo Clinic in Arizona)Martha Q. Lacy(Mayo Clinic in Arizona)John A. Lust(Mayo Clinic in Arizona)Craig B. Reeder(Mayo Clinic in Arizona)Vivek Roy(Mayo Clinic in Florida)Stephen J. Russell(Mayo Clinic in Arizona)Kristen E. Detweiler Short(Mayo Clinic in Arizona)A. Keith Stewart(Mayo Clinic in Arizona)Thomas E. Witzig(Mayo Clinic in Arizona)Steven R. Zeldenrust(Mayo Clinic in Arizona)Robert J. Dalton(Mayo Clinic Health System)S. Vincent Rajkumar(Mayo Clinic in Arizona)P. Leif Bergsagel(Mayo Clinic in Arizona)
Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisMedicinePlasma cell neoplasmMultiple myelomaMalignancyIntensive care medicineDiseaseClinical trialOncologyRandomized controlled trialInternal medicine
MeSH terms
Antineoplastic Combined Chemotherapy ProtocolsHumansMultiple MyelomaBiomarkers, TumorPractice Guidelines as TopicRisk AssessmentStem Cell Transplantation
Funding
- Amgen
- Pfizer
- Biogen
- Celgene
- IC Design Education Center
- Genentech
- Takeda Oncology
- National Cancer Institute
Citations
623
FWCI
14.54
field-weighted impact
References
183
Percentile
99%
vs. same field & year
Citations per year
Cited by
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
Leukemia · 2013 · 1,380 citations
Multiple Myeloma: Diagnosis and Treatment
Mayo Clinic Proceedings · 2016 · 806 citations
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Leukemia · 2011 · 720 citations
IMWG consensus on risk stratification in multiple myeloma
Leukemia · 2013 · 594 citations
References
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Leukemia · 2009 · 875 citations
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Mayo Clinic Proceedings · 2008 · 3,066 citations
Improved survival in multiple myeloma and the impact of novel therapies
Blood · 2007 · 2,238 citations
Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma
British Journal of Haematology · 2005 · 399 citations
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Leukemia · 2007 · 835 citations
Cancer Statistics, 2009
CA A Cancer Journal for Clinicians · 2009 · 9,714 citations
International Staging System for Multiple Myeloma
Journal of Clinical Oncology · 2005 · 2,894 citations
Small Cell Lung Cancer
Mayo Clinic Proceedings · 2008 · 512 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.